Showing results (2731-2740 of 3,679) with videos related to
Sort By:
Pageof 368
Journal of Autoimmunity|July 3, 2025
STAT3 phosphorylation in the rheumatoid arthritis immunological synapseHila Novak-Kotzer, Jesusa Capera, Ashwin Jainarayanan, et al.Rheumatology (Oxford, England)|August 25, 2023
Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseasesPeter C Taylor, Ernest Choy, Xenofon Baraliakos, et al.Journal of Environmental Management|June 24, 2010
A free-enzyme catalyst for the bioremediation of environmental atrazine contaminationColin Scott, Steve E Lewis, Rob Milla, et al.Science (New York, N.Y.)|February 10, 2007
An intrinsic bond-centered electronic glass with unidirectional domains in underdoped cupratesY Kohsaka, C Taylor, K Fujita, et al.The American Journal of Sports Medicine|December 2, 2004
Functional bracing after anterior cruciate ligament reconstruction: a prospective, randomized, multicenter studyEdward R McDevitt, Dean C Taylor, Mark D Miller, et al.Infection and Immunity|October 27, 2004
Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potentialClíona A O'dwyer, Karen Reddin, Denis Martin, et al.Arthritis and Rheumatism|April 13, 2004
Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritisP C Taylor, A Steuer, J Gruber, et al.The New Phytologist|October 14, 2022
Thermal sensitivity across forest vertical profiles: patterns, mechanisms, and ecological implicationsNidhi Vinod, Martijn Slot, Ian R McGregor, et al.Journal of General Internal Medicine|April 14, 2016
Does Motivation Matter? Analysis of a Randomized Trial of Proactive Outreach to VA SmokersElisheva R Danan, Anne M Joseph, Scott E Sherman, et al.Arthritis and Rheumatism|December 31, 2005
Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritisP C Taylor, A Steuer, J Gruber, et al.Pageof 368